Journal Article Multicenter Study Randomized Controlled Trial Epublish
PubMed: 40646458 DOI: 10.1186/s12877-025-06122-1
Impact of collaborative pharmaceutical care on older inpatients' medication safety: multicentre stepped-wedge cluster randomised trial (MEDREV Study).
BMC Geriatr 25(1):516
Authors: Géraldine Leguelinel-Blache, Sophie Bouvet, Pierrick Bedouch, Bérengère Bachelet, Catherine Chenailler, Thomas Dantin, Laure Geneletti, Alexia Janes, Florence Scher, Bogdan Cireașă, Jean-Marie Kinowski, Christel Castelli, Clarisse Roux-Marson
Affiliations
- Pharmacy Department, Nîmes University Hospital, University of Montpellier, Nîmes, France.
- Institute Desbrest of Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier, France.
- Department of Law and Health Economics, Faculty of Pharmacy, University of Montpellier, Montpellier, France.
- Institute Desbrest of Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier, France.
- Department of Biostatistics, Clinical Epidemiology, Public Health, and Innovation in Methodology, University of Montpellier, Nîmes, France.
- UMR 5525, University of Grenoble Alpes, CNRS, Grenoble INP, TIMC, VetAgro Sup, 38000, Grenoble, France.
- Pharmacy Department, Grenoble Alpes University Hospital, University of Grenoble Alpes, Grenoble, France.
- Pharmacy Department, Toulouse University Hospital, Toulouse, France.
- Pharmacy Department, Rouen University Hospital, Rouen, France.
- Pharmacy Department, Nice University Hospital, Nice, France.
- Pharmacy Department, Nîmes University Hospital, University of Montpellier, Nîmes, France.
- Pharmacy Department, Strasbourg University Hospital, Strasbourg, France.
- Department of Law and Health Economics, Faculty of Pharmacy, University of Montpellier, Montpellier, France.
- Department of Innovation, Communication and Market, University of Montpellier, Montpellier, France.
- AESIO SANTE Research, Beausoleil Clinic, Montpellier, France.
Abstract
BACKGROUND
Improving medication safety implies patient-centred multidisciplinary cooperation. During the hospital stay for an acute care episode, the patient needs a comprehensive management to guarantee the best possible outcome.
METHODS
The study was designed as a non-blinded, multicentre stepped-wedge cluster randomised clinical trial, taking place in six French University Hospitals. Each cluster began with the control period in which standard care did not include pharmaceutical intervention. Every 14-day period, one hospital unit was electronically randomised to switch to the intervention period until all cluster groups received the intervention, which consisted of collaborative pharmaceutical care (CPC) associating medication reconciliation at hospital admission, pharmaceutical analysis of the medication order, medication review and collaborative meeting. The primary outcome was assessing the intervention through the rate of patients with at least one medication error (ME) on the admission medication order (such as omission, wrong dose or wrong route of administration), comparing the two periods.
RESULTS
CPC decreased the rate of patients with at least one ME from 88.9% (n = 243) to 29.2% (n = 267) (p < 0.0001). A total of 1817 MEs were discovered, of which 1121 (61.7%) were in the control period and 696 (38.3%) in the intervention period before resolution by the CPC. After resolving 567 of them, 129 medication errors still remained after CPC. So, a median of 3 MEs [IQR = 1;6] per patient were detected in the control period vs 0 [IQR = 0;1] after CPC in the intervention period (p < 0.0001). Patients were 21-times more likely to avoid a ME with CPC (OR: 20.8 [8.3;52.2], p < 0.0001). The rate of patients with a 2-3 critical ME level decreased from 70.8% to 12.0% in the control vs intervention periods respectively (OR: 18.4 [7.7;43.9], p < 0.0001).
CONCLUSIONS
CPC can prevent the occurrence of MEs and thus can improve inpatients' medication management and safety. Pharmacists play a key role in combating medication-related harm in healthcare settings.
TRIAL REGISTRATION
This study is registered on ClinicalTrials.gov with the reference number NCT02598115 (2015-11-04).
MeSH
Safety, Pharmaceutical Preparations, Medication Errors, Geriatrics